Chin, Alfred C.
Day, Sharlene M.
Article History
First Online: 11 July 2022
Competing interests
: S.M.D. receives research funding from Bristol Myers Squibb, consults for Tenaya Therapeutics and Pfizer, and is on the data monitoring board for Cytokinetics. A.C.C. declares no competing interests.